Arcadia Biosciences, Inc. (RKDA)
↓ Download CSV- Sector Mining
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, Arcadia Biosciences, Inc. reported revenue of $4.86M, down 3.7% from the prior year. The company ran a net loss, with a net margin of -48.1%. It held $6.55M in total assets against $2.41M in total liabilities.
Key ratios (FY2025)
-51.5%
Operating margin
-48.1%
Net margin
-56.5%
Return on equity
-3.7%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.86M | $5.04M | $4.45M | $7.42M | $6.78M | $8.03M | $1.17M | $1.46M | $4.03M | — |
| Cost of Revenue | $3.10M | $2.96M | $2.17M | $6.10M | $8.71M | $5.20M | — | — | — | — |
| Operating Income | -$2.50M | -$3.65M | -$6.10M | -$14.01M | -$35.53M | -$12.78M | -$19.38M | -$16.87M | -$14.31M | -$18.62M |
| Net Income | -$2.34M | -$7.04M | -$13.98M | -$15.38M | -$14.66M | -$4.66M | -$28.80M | -$13.48M | -$15.71M | -$19.62M |
| EPS (Diluted) | $-1.71 | $-5.17 | $-11.29 | $-25.65 | $-27.56 | — | — | — | — | — |
| Total Assets | $6.55M | $13.52M | $19.70M | $28.92M | $43.92M | $47.35M | $32.57M | $24.02M | $16.57M | $56.57M |
| Total Liabilities | $2.41M | $7.29M | $7.00M | $8.02M | $12.72M | $18.80M | $24.25M | $11.21M | $8.56M | $34.38M |
| Shareholders' Equity | $4.14M | $6.22M | $12.70M | $20.90M | $31.20M | $28.55M | $8.32M | $12.81M | $8.01M | — |
| Cash & Equivalents | $259.0K | $4.24M | $6.52M | $20.64M | $28.68M | $14.04M | $8.42M | $12.00M | $9.12M | $2.01M |
| Operating Cash Flow | -$4.74M | -$9.63M | -$15.29M | -$13.98M | -$25.87M | -$30.22M | -$17.20M | -$13.63M | -$13.96M | — |
| Capital Expenditures | $0 | $16.0K | $5.0K | $72.0K | $1.01M | $2.33M | $1.48M | $250.0K | $79.0K | $231.0K |
| Shares Outstanding | 1.37M | 1.36M | 1.29M | 616.1K | 554.6K | 13.45M | 8.65M | 4.77M | 2.13M | 2.22M |